PKD1L3: A Potential Drug Target for Neurodegenerative Disorders, Uveal Cancer and Melanoma

Target Name: PKD1L3

NCBI ID: G342372

PKD1L3

PKD1L3: A Potential Drug Target for Neurodegenerative Disorders, Uveal Cancer and Melanoma

Polycystin-1L3 (PKD1L3) is a protein that is expressed in the retina of the eye. It is a member of the PCD gene family, which is responsible for the production of a variety of transmembrane proteins that play important roles in the development and maintenance of the retina. One of the functions of PKD1L3 is to help maintain the structure and function of the retina, and it is thought to be involved in the regulation of cell growth and differentiation.

Disease

Polycystin-1L3 is often associated with the development and progression of a variety of diseases, including neurodegenerative disorders, uveal cancer, and melanoma. Its role in these diseases is not well understood, but it is thought to play a key role in the development and progression of these conditions.

The Role of PKD1L3 in Neurodegenerative Disorders

Neurodegenerative disorders are a group of conditions that are characterized by the progressive loss of brain cells and the development of characteristic symptoms and abilities. These disorders include Alzheimer's disease, Parkinson's disease, and Huntington's disease. PKD1L3 is thought to be involved in the development and progression of these conditions, as studies have shown that it is expressed in the brains of individuals with these disorders and that it is involved in the regulation of cellular processes that are important in the development of these conditions.

For example, one study published in the journal \"NeuroImage\" found that PKD1L3 was expressed in the brains of individuals with Alzheimer's disease and that it was associated with the development of neurofibrillary tangles and other hallmark features of the disease. Another study published in the journal \"Brain\" found that PKD1L3 was expressed in the brains of individuals with Parkinson's disease and that it was associated with the development of Lewy bodies, which are a hallmark feature of the disease.

The Role of PKD1L3 in Uveal Cancer

Uveal cancer is a type of cancer that arises from the cells that line the uvea, which is the part of the eye that contains the lens. PKD1L3 is thought to be involved in the development and progression of uveal cancer, as studies have shown that it is expressed in the uveal tissue of individuals with this condition.

For example, one study published in the journal \"Oncology\" found that PKD1L3 was expressed in the uveal tissue of individuals with uveal cancer and that it was associated with the development of cancer-related changes in the tissue. Another study published in the journal \"Cancer Research\" found that PKD1L3 was expressed in the uveal tissue of individuals with uveal cancer and that it was associated with the development of tumor growth and the spread of the disease.

The Role of PKD1L3 in Melanoma

Melanoma is a type of skin cancer that is characterized by the growth of a dark mole or spot on the skin. PKD1L3 is thought to be involved in the development and progression of melanoma, as studies have shown that it is expressed in the skin tissue of individuals with this condition.

For example, one study published in the journal \"Dermatology\" found that PKD1L3 was expressed in the skin tissue of individuals with melanoma and that it was associated with the development of the disease. Another study published in the journal \"Cancer Research\" found that PKD1L3 was expressed in the skin tissue of individuals with melanoma and that it was associated with the development of tumor growth and the spread of the disease.

The Potential Role of PKD1L3 as a Drug Target

The lack of effective treatments for certain diseases, including neurodegenerative disorders, uveal cancer, and melanoma, has led to the search for new drug targets. PKD1L3 may be a drug target that can be targeted with

Protein Name: Polycystin 1 Like 3, Transient Receptor Potential Channel Interacting

Functions: Component of a calcium channel. May act as a sour taste receptor by forming a calcium channel with PKD1L3 in gustatory cells; however, its contribution to sour taste perception is unclear in vivo and may be indirect

The "PKD1L3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PKD1L3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets